The Microbiome in Obesity, Diabetes, and NAFLD: What is Your Gut Telling Us?

Current Hepatology Reports

Volumn 15, Issue 2, 2016, Pages 96-102

  Adams, Leon A ^a,b   Morrison, Mark ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bacteria; Gut; Mechanisms; Meta genomics; Metabolome; Pyrosequencing

Indexed keywords

EID: 85015696872     PISSN: None     EISSN: 21959595     Source Type: Journal    
DOI: 10.1007/s11901-016-0299-5     Document Type: Article

References (52)

1. L. Zhao The gut microbiota and obesity: from correlation to causality Nat Rev Microbiol 2013 11 639 47 1:CAS:528:DC%2BC3sXht1WgsrnJ 10.1038/nrmicro3089 23912213
2. H.J. Flint K.P. Scott P. Louis et al. The role of the gut microbiota in nutrition and health Nat Rev Gastroenterol Hepatol 2012 9 577 89 1:CAS:528:DC%2BC38XhsVKmurrF 10.1038/nrgastro.2012.156 22945443
3. R.E. Ley P.J. Turnbaugh S. Klein et al. Microbial ecology: human gut microbes associated with obesity Nature 2006 444 1022 3 1:CAS:528:DC%2BD28XhtlemtLvM 10.1038/4441022a 17183309
4. D. Aguirre de Carcer P.O. Cuiv T. Wang et al. Numerical ecology validates a biogeographical distribution and gender-based effect on mucosa-associated bacteria along the human colon Isme J 2011 5 801 9 1:CAS:528:DC%2BC3MXkvFahsLw%3D 10.1038/ismej.2010.177 21124491
5. X.C. Morgan C. Huttenhower Chapter 12: human microbiome analysis PLoS Comput Biol 2012 8 e1002808 1:CAS:528:DC%2BC3sXotVCmuw%3D%3D 10.1371/journal.pcbi.1002808 23300406 3531975
6. J. Qin R. Li J. Raes et al. A human gut microbial gene catalogue established by metagenomic sequencing Nature 2010 464 59 65 1:CAS:528:DC%2BC3cXislahsLc%3D 10.1038/nature08821 20203603 3779803
7. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–14.
8. R.S. Mandal S. Saha S. Das Metagenomic surveys of gut microbiota Genomics Proteomics Bioinformatics 2015 13 148 58 10.1016/j.gpb.2015.02.005 26184859 4563348
9. H. Tilg A.R. Moschen A. Kaser Obesity and the microbiota Gastroenterology 2009 136 1476 83 10.1053/j.gastro.2009.03.030 19327360
10. P.J. Turnbaugh R.E. Ley M.A. Mahowald et al. An obesity-associated gut microbiome with increased capacity for energy harvest Nature 2006 444 1027 31 10.1038/nature05414 17183312
11. P.J. Turnbaugh M. Hamady T. Yatsunenko et al. A core gut microbiome in obese and lean twins Nature 2009 457 480 4 1:CAS:528:DC%2BD1MXotlOlsw%3D%3D 10.1038/nature07540 19043404 2677729
12. J.P. Furet L.C. Kong J. Tap et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers Diabetes 2010 59 3049 57 1:CAS:528:DC%2BC3MXlsVamtg%3D%3D 10.2337/db10-0253 20876719 2992765
13. H. Zhang J.K. DiBaise A. Zuccolo et al. Human gut microbiota in obesity and after gastric bypass Proc Natl Acad Sci U S A 2009 106 2365 70 1:CAS:528:DC%2BD1MXit12jtL4%3D 10.1073/pnas.0812600106 19164560 2629490
14. A. Schwiertz D. Taras K. Schafer et al. Microbiota and SCFA in lean and overweight healthy subjects Obesity (Silver Spring) 2010 18 190 5 10.1038/oby.2009.167
15. C. Kasai K. Sugimoto I. Moritani et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing BMC Gastroenterol 2015 15 100 10.1186/s12876-015-0330-2 26261039 4531509
16. E. Le Chatelier T. Nielsen J. Qin et al. Richness of human gut microbiome correlates with metabolic markers Nature 2013 500 541 6 10.1038/nature12506 23985870 Demonstrates that the gut bacteria genome is less diverse in obese individuals and may predict an obese phenotype more accurately than the human genome
17. A. Vrieze E. Van Nood F. Holleman et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome Gastroenterology 2012 143 913 6 e7 1:CAS:528:DC%2BC38Xht1GlurzE 10.1053/j.gastro.2012.06.031 22728514 A proof of principle human study demonstrating changes in insulin sensitivity following wide-spread alteration in the gut microbiome by performing faecal transplantation from lean to obese individuals
18. S.H. Duncan G.E. Lobley G. Holtrop et al. Human colonic microbiota associated with diet, obesity and weight loss Int J Obes (Lond) 2008 32 1720 4 1:STN:280:DC%2BD1cjktFGjuw%3D%3D 10.1038/ijo.2008.155
19. M. Million E. Angelakis M. Maraninchi et al. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli Int J Obes (Lond) 2013 37 1460 6 1:STN:280:DC%2BC3svjtFWqtQ%3D%3D 10.1038/ijo.2013.20
20. J.K. Goodrich J.L. Waters A.C. Poole et al. Human genetics shape the gut microbiome Cell 2014 159 789 99 1:CAS:528:DC%2BC2cXhvV2msrnJ 10.1016/j.cell.2014.09.053 25417156 4255478
21. S. Tims C. Derom D.M. Jonkers et al. Microbiota conservation and BMI signatures in adult monozygotic twins Isme J 2013 7 707 17 1:CAS:528:DC%2BC3sXksVKmtb4%3D 10.1038/ismej.2012.146 23190729 3603393
22. De Filippis F, Pellegrini N, Vannini L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2015. doi:10.1136/gutjnl-2015-309957.
23. L.A. David C.F. Maurice R.N. Carmody et al. Diet rapidly and reproducibly alters the human gut microbiome Nature 2014 505 559 63 1:CAS:528:DC%2BC2cXhtFOls78%3D 10.1038/nature12820 24336217 3957428 Demonstrates the ability of diet to alter the gut microbiome, thereby offering hope for targeted nutritional therapy to reduce metabolic diseases
24. G.D. Wu J. Chen C. Hoffmann et al. Linking long-term dietary patterns with gut microbial enterotypes Science 2011 334 105 8 1:CAS:528:DC%2BC3MXht1Gms77K 10.1126/science.1208344 21885731 3368382
25. C. Haro M. Montes-Borrego O.A. Rangel-Zuniga et al. Two healthy diets modulate gut microbial community improving insulin sensitivity in a human obese population J Clin Endocrinol Metab 2016 101 233 42 1:CAS:528:DC%2BC28XjtlSnsbk%3D 10.1210/jc.2015-3351 26505825
26. J.H. Hehemann G. Correc T. Barbeyron et al. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota Nature 2010 464 908 12 1:CAS:528:DC%2BC3cXktlynsbw%3D 10.1038/nature08937 20376150
27. N. Larsen F.K. Vogensen F.W. van den Berg et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults PLoS One 2010 5 e9085 10.1371/journal.pone.0009085 20140211 2816710
28. J. Qin Y. Li Z. Cai et al. A metagenome-wide association study of gut microbiota in type 2 diabetes Nature 2012 490 55 60 1:CAS:528:DC%2BC38XhsVaqt7fJ 10.1038/nature11450 23023125
29. S. Miquel R. Martin O. Rossi et al. Faecalibacterium prausnitzii and human intestinal health Curr Opin Microbiol 2013 16 255 61 1:CAS:528:DC%2BC3sXhtVKqsr7K 10.1016/j.mib.2013.06.003 23831042
30. L.K. Brahe E. Le Chatelier E. Prifti et al. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity Nutr Diabetes 2015 5 e159 1:CAS:528:DC%2BC2MXhtFOjt7vP 10.1038/nutd.2015.9 26075636 4491860
31. H. Tilg A.R. Moschen Microbiota and diabetes: an evolving relationship Gut 2014 63 1513 21 1:CAS:528:DC%2BC2cXhvVyitr7P 10.1136/gutjnl-2014-306928 24833634
32. K. Forslund F. Hildebrand T. Nielsen et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota Nature 2015 528 262 6 1:CAS:528:DC%2BC2MXhvFemsbjN 10.1038/nature15766 26633628 A landmark paper demonstrating the importance of potential confounding variables (in this case metformin medication) in interpretating relationships between gut microbiota composition and disease phenotypes
33. Mouzaki M, Comelli E, Arendt BM, et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology. 2013;58:120–7.
34. M. Raman I. Ahmed P.M. Gillevet et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 2013 11 868 75 e1-3 1:CAS:528:DC%2BC3sXovVWgsbk%3D 10.1016/j.cgh.2013.02.015 23454028
35. W. Jiang N. Wu X. Wang et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease Sci Rep 2015 5 8096 1:CAS:528:DC%2BC2MXhtFKjurfK 10.1038/srep08096 25644696 4314632
36. V.W. Wong C.H. Tse T.T. Lam et al. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis—a longitudinal study PLoS One 2013 8 e62885 1:CAS:528:DC%2BC3sXntlClsrs%3D 10.1371/journal.pone.0062885 23638162 3636208
37. E. Munukka S. Pekkala P. Wiklund et al. Gut-adipose tissue axis in hepatic fat accumulation in humans J Hepatol 2014 61 132 8 1:CAS:528:DC%2BC2cXnsFeqtbs%3D 10.1016/j.jhep.2014.02.020 24613361
38. L. Zhu S.S. Baker C. Gill et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH Hepatology 2013 57 601 9 1:CAS:528:DC%2BC3sXit1Wgsbo%3D 10.1002/hep.26093 23055155
39. Boursier J, Mueller O, Barret M, et al. The severity of NAFLD is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;63:764–75. A human study demonstrating changes in the gut microbiome according to severity of liver injury in nonalcoholic fatty liver disease.
40. F. Backhed J.K. Manchester C.F. Semenkovich et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice Proc Natl Acad Sci U S A 2007 104 979 84 1:CAS:528:DC%2BD2sXhtVSitbo%3D 10.1073/pnas.0605374104 17210919 1764762
41. S. Rabot M. Membrez A. Bruneau et al. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism Faseb J 2010 24 4948 59 1:CAS:528:DC%2BC3cXhsFOms7rE 10.1096/fj.10-164921 20724524
42. V.K. Ridaura J.J. Faith F.E. Rey et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 2013 341 1241214 10.1126/science.1241214 24009397 Landmark animal model study demonstrating that the ‘transmissible’ obesity trait via the gut microbiome is dependent upon diet
43. L.M. Cox S. Yamanishi J. Sohn et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences Cell 2014 158 705 21 1:CAS:528:DC%2BC2cXhtlymtLjP 10.1016/j.cell.2014.05.052 25126780 4134513
44. J. Henao-Mejia E. Elinav C. Jin et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 2012 482 179 85 1:CAS:528:DC%2BC38Xhs1GgsLc%3D 22297845 3276682 Precipitation of gut dysbiosis predisposes to liver injury in a mouse model of NAFLD. The phenotype is transmissible and preventable with antibiotics. Offers evidence that altering the gut microbiome may be a future therapeutic option for NASH
45. N. Fei L. Zhao An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice Isme J 2013 7 880 4 1:CAS:528:DC%2BC3sXksVKmtLk%3D 10.1038/ismej.2012.153 23235292 3603399
46. A. Everard C. Belzer L. Geurts et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity Proc Natl Acad Sci U S A 2013 110 9066 71 1:CAS:528:DC%2BC3sXhtFait7rM 10.1073/pnas.1219451110 23671105 3670398
47. S. Park J.H. Bae Probiotics for weight loss: a systematic review and meta-analysis Nutr Res 2015 35 566 75 1:CAS:528:DC%2BC2MXpsVykur8%3D 10.1016/j.nutres.2015.05.008 26032481
48. G. Tarantino C. Finelli Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease Future Microbiol 2015 10 889 902 1:CAS:528:DC%2BC2MXoslOktro%3D 10.2217/fmb.15.13 26000656
49. Y. Ruan J. Sun J. He et al. Effect of probiotics on glycemic control: a systematic review and meta-analysis of randomized, controlled trials PLoS One 2015 10 e0132121 10.1371/journal.pone.0132121 26161741 4498615
50. Vrieze A, Out C, Fuentes S, et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol. 2014;60:824–31.
51. B.A. Neuschwander-Tetri R. Loomba A.J. Sanyal et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Lancet 2015 385 956 65 1:CAS:528:DC%2BC2cXhvV2gtr%2FE 10.1016/S0140-6736(14)61933-4 25468160 4447192
52. S. Mudaliar R.R. Henry A.J. Sanyal et al. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease Gastroenterology 2013 145 574 82 e1 1:CAS:528:DC%2BC3sXhtlyrsr3O 10.1053/j.gastro.2013.05.042 23727264